Endothelial cell clonal expansion in the development of cerebral cavernous malformations.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31235698.
- Also identified by DOI 10.1038/s41467-019-10707-x and PMC identifier 6591323.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Cerebral cavernous malformation (CCM) is a neurovascular familial or sporadic disease that is characterised by capillary-venous cavernomas, and is due to loss-of-function mutations to any one of three CCM genes. Familial CCM follows a two-hit mechanism similar to that of tumour suppressor genes, while in sporadic cavernomas only a small fraction of endothelial cells shows mutated CCM genes. We reported that in mouse models and in human patients, endothelial cells lining the lesions have different features from the surrounding endothelium, as they express mesenchymal/stem-cell markers. Here we show that cavernomas originate from clonal expansion of few Ccm3-null endothelial cells that express mesenchymal/stem-cell markers. These cells then attract surrounding wild-type endothelial cells, inducing them to express mesenchymal/stem-cell markers and to contribute to cavernoma growth. These characteristics of Ccm3-null cells are reminiscent of the tumour-initiating cells that are responsible for tumour growth. Our data support the concept that CCM has benign tumour characteristics.
Medical subject headings
- Apoptosis Regulatory Proteins
- Central Nervous System Neoplasms
- Endothelial Cells
- Hemangioma, Cavernous, Central Nervous System
- Intracellular Signaling Peptides and Proteins
- Membrane Proteins
- Proto-Oncogene Proteins